AR and prostate carcinoma: These castrate-resistant prostate cancer cell lines do not undergo apoptosis when androgens are depleted or androgens antagonists are used; however, they stop proliferating and activate cell death if the AR protein level is reduced below a critical level both in vitro[14], [16], [17] and in vivo[18].